Home » Almac Teams with Queen's Univ. on Cancer PGx

Almac Teams with Queen's Univ. on Cancer PGx

Sep 07, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Almac today said that it is teaming up with researchers at Queen's University, Belfast to develop pharmacogenomics tests for a variety of cancers.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Articles

Apr 15, 2014

Almac Diagnostics Business Receives Clinical Lab Permit from New York

Jun 10, 2014

Almac's Ovarian Cancer Patient Stratification Test Could Be Used to Select Treatment for Other Diseases

Premium
Jul 01, 2014

Almac Diagnostics Sees 'Significant' Pharma Interest in Cancer Subgroup Typing Test

Premium
Sep 29, 2014

Agilent, Univ. of Toronto to Create Metabolomics MRM Library

May 06, 2014

Myriad Signs Contract with UnitedHealthcare for MyRisk Hereditary Cancer Risk Panel

Oct 17, 2014

Myriad's Prolaris Gets Draft LCD; High Demand for myRisk Leads to Lower Q1 Revenue Expectations

The Scan

Ancient Wheat

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

'High School Never Ends'

Joel Achenbach explores at National Geographic why people find science difficult to believe.

This Week in Science

In Science this week: gene linked to expansion of the human neocortex, and more.

Bit of an Increase

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.

What's Popular?

In Clinical & Translational

  1. Study Highlights High False Positive Rate of NIPT for Some Disorders Despite High Specificity

    Premium

  2. Quest Launches 34-Gene Cancer Dx with Plans for Expanded Panel in 2015; Collaborating with MSKCC

    Premium

  3. NantHealth Adds $250M to Financing Round

  4. NMTC's 'Italian Soap Opera' Leaves Luminex Crowing 'Nice Win' While GenMark Cuts Guidance

    Premium

  5. Life Tech's AmpliSeq BRCA 1/2 Panel Launch Puts Pressure on Long-Term Myriad Monopoly

    Premium

Sponsorships

Privacy Policy.  Copyright © 2015 Genomeweb LLC.  All Rights Reserved.